<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:blogger='http://schemas.google.com/blogger/2008' xmlns:georss='http://www.georss.org/georss' xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-3448774753580776110</id><updated>2024-11-01T03:34:25.945-07:00</updated><category term="Bunavail"/><category term="Sublocade. Subutex"/><category term="Zubsolv"/><category term="addiction"/><category term="addiction treatment"/><category term="alcoholism"/><category term="buprenorphine"/><category term="cravings"/><category term="detox"/><category term="outpatient"/><category term="outpatient detox"/><category term="sober"/><category term="substance abuse"/><title type='text'>dagmarliepamd</title><subtitle type='html'>  Learn More at &lt;a href=&quot;http://dagmarliepamd.com&quot;&gt;dagmarliepamd.com&lt;/a&gt;</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='https://dagmarliepamd.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/3448774753580776110/posts/default'/><link rel='alternate' type='text/html' href='https://dagmarliepamd.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>Anonymous</name><uri>http://www.blogger.com/profile/02352035717099209091</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>2</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-3448774753580776110.post-6610571242507195382</id><published>2018-03-01T15:14:00.000-08:00</published><updated>2018-03-01T15:15:57.759-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="addiction"/><category scheme="http://www.blogger.com/atom/ns#" term="addiction treatment"/><category scheme="http://www.blogger.com/atom/ns#" term="alcoholism"/><category scheme="http://www.blogger.com/atom/ns#" term="Bunavail"/><category scheme="http://www.blogger.com/atom/ns#" term="buprenorphine"/><category scheme="http://www.blogger.com/atom/ns#" term="cravings"/><category scheme="http://www.blogger.com/atom/ns#" term="detox"/><category scheme="http://www.blogger.com/atom/ns#" term="outpatient"/><category scheme="http://www.blogger.com/atom/ns#" term="outpatient detox"/><category scheme="http://www.blogger.com/atom/ns#" term="sober"/><category scheme="http://www.blogger.com/atom/ns#" term="Sublocade. Subutex"/><category scheme="http://www.blogger.com/atom/ns#" term="substance abuse"/><category scheme="http://www.blogger.com/atom/ns#" term="Zubsolv"/><title type='text'>Treatment for Opioid Use Disorder Continues to Evolve - a brief summary</title><content type='html'>&lt;div class=&quot;MsoNormal&quot; style=&quot;mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;&quot;&gt;
&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;margin-left: .5in; mso-layout-grid-align: none; mso-list: l1 level1 lfo2; mso-pagination: none; tab-stops: 11.0pt .5in; text-align: center; text-autospace: none; text-indent: -.5in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;&lt;b&gt;&lt;span style=&quot;mso-font-kerning: .5pt;&quot;&gt;&lt;span style=&quot;mso-tab-count: 1;&quot;&gt;&amp;nbsp; &amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;Currently
there are basically 6 recognized treatment approaches that include counseling
and psychosocial support in various treatment settings to treat moderate to
severe opioid use disorder (heroin and/or pain medication addiction). All have
certain advantages and disadvantages which can be summarized as follows:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;br /&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;1.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Cold
turkey, or non-medical detox, followed by complete abstinence&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: .5in; mso-layout-grid-align: none; mso-list: l2 level1 lfo3; mso-pagination: none; tab-stops: 11.0pt .5in; text-autospace: none; text-indent: -.5in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-font-family: Arial; mso-fareast-language: JA;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;•&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;&amp;nbsp;Advantages: low cost&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: .5in; mso-layout-grid-align: none; mso-list: l2 level1 lfo3; mso-pagination: none; tab-stops: 11.0pt .5in; text-autospace: none; text-indent: -.5in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-font-family: Arial; mso-fareast-language: JA;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;•&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;Disadvantages: high failure
rate&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;2.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Medically
prescribed detox or withdrawal management, with or without buprenorphine or
methadone used in a taper, followed by abstinence&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: .5in; mso-layout-grid-align: none; mso-list: l3 level1 lfo4; mso-pagination: none; tab-stops: 11.0pt .5in; text-autospace: none; text-indent: -.5in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-font-family: Arial; mso-fareast-language: JA;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;•&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;Advantages: less discomfort
during withdrawal&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: .5in; mso-layout-grid-align: none; mso-list: l3 level1 lfo4; mso-pagination: none; tab-stops: 11.0pt .5in; text-autospace: none; text-indent: -.5in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-font-family: Arial; mso-fareast-language: JA;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;•&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;Disadvantages:&amp;nbsp;high
failure rate after treatment episode is complete&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;3.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Detox
(medical or non-medical) followed by initiation of a naltrexone containing
product such as Vivitrol, Revia or a non-FDA approved naltrexone implant&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: .5in; mso-layout-grid-align: none; mso-list: l4 level1 lfo5; mso-pagination: none; tab-stops: 11.0pt .5in; text-autospace: none; text-indent: -.5in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-font-family: Arial; mso-fareast-language: JA;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;•&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;Advantages: Effective as long
as the individual remains motivated or able to stay on the naltrexone as
prescribed&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: .5in; mso-layout-grid-align: none; mso-list: l4 level1 lfo5; mso-pagination: none; tab-stops: 11.0pt .5in; text-autospace: none; text-indent: -.5in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-font-family: Arial; mso-fareast-language: JA;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;•&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;Disadvantages: Abstinence
from all opioids is usually required for several days prior to initiation of
treatment.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;4.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Methadone
maintenance&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: .5in; mso-layout-grid-align: none; mso-list: l5 level1 lfo6; mso-pagination: none; tab-stops: 11.0pt .5in; text-autospace: none; text-indent: -.5in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-font-family: Arial; mso-fareast-language: JA;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;•&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;Advantages: effective for
select individuals using established, well studied treatment protocols&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: .5in; mso-layout-grid-align: none; mso-list: l5 level1 lfo6; mso-pagination: none; tab-stops: 11.0pt .5in; text-autospace: none; text-indent: -.5in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-font-family: Arial; mso-fareast-language: JA;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;•&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;Disadvantages: Restrictive
and often impractical due to current Federal laws&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;5.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Oral
administration of a buprenorphine containing product such as Suboxone, Subutex,
Zubsolv, Bunavail or their generic equivalents.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: .5in; mso-layout-grid-align: none; mso-list: l6 level1 lfo7; mso-pagination: none; tab-stops: 11.0pt .5in; text-autospace: none; text-indent: -.5in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-font-family: Arial; mso-fareast-language: JA;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;•&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;&amp;nbsp;Advantages: Effective,
well tolerated, accessible through a licensed prescriber&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: .5in; mso-layout-grid-align: none; mso-list: l6 level1 lfo7; mso-pagination: none; tab-stops: 11.0pt .5in; text-autospace: none; text-indent: -.5in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-font-family: Arial; mso-fareast-language: JA;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;•&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;Disadvantages: problematic in
certain settings such as incarceration, unstable housing, and sober living
homes due to misuse and diversion. Difficult to monitor treatment compliance at
times.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;6.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Probuphine
which is a 6 month, long-acting buprenorphine implant in the arm&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;br /&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: .5in; mso-layout-grid-align: none; mso-list: l7 level1 lfo8; mso-pagination: none; tab-stops: 11.0pt .5in; text-autospace: none; text-indent: -.5in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-font-family: Arial; mso-fareast-language: JA;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;•&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;Advantages: effective in a
select population. Addresses many concerns over medication compliance,
diversion or misuse during the 6-month implant period.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: .5in; mso-layout-grid-align: none; mso-list: l7 level1 lfo8; mso-pagination: none; tab-stops: 11.0pt .5in; text-autospace: none; text-indent: -.5in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-font-family: Arial; mso-fareast-language: JA;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;•&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;Disadvantages: must be
administered in a structured medical setting by a physician that has been
trained and certified for insertion and removal of the implants using minor
surgical technique. Possible complications related to performing this type of
invasive surgical procedure.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;br /&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;There
is now a 7th approach that will be available starting March 2018 that is
expected to be effective, accessible and able to address the frequent problems
of compliance, diversion, and misuse of buprenorphine containing products. This
new product is being introduced by the same company that released Suboxone in
2003 and revolutionized how we look at and treat opioid use disorders. This new
product received FDA approval in November 2017 based on favorable data as a
completely new buprenorphine delivery system and will be marketed as Sublocade.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;Sublocade
is a Schedule III (CIII) once monthly buprenorphine extended-release
subcutaneous injection that can easily be administered by a physician or other
qualified healthcare provider that is currently licensed to prescribe
buprenorphine containing products.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot;; mso-fareast-language: JA;&quot;&gt;Because
Sublocade is injected once a month in a controlled setting under medical
supervision, the chance of misuse or diversion is likely to be very low. It is
expected that most insurances will cover this treatment as part of a structured
treatment program that includes counseling and psychosocial support.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;!--[if !mso]&gt;
&lt;style&gt;
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
&lt;/style&gt;
&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;o:OfficeDocumentSettings&gt;
  &lt;o:AllowPNG/&gt;
 &lt;/o:OfficeDocumentSettings&gt;
&lt;/xml&gt;&lt;![endif]--&gt;

&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves&gt;false&lt;/w:TrackMoves&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;JA&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:EnableOpenTypeKerning/&gt;
   &lt;w:DontFlipMirrorIndents/&gt;
   &lt;w:OverrideTableStyleHps/&gt;
   &lt;w:UseFELayout/&gt;
  &lt;/w:Compatibility&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;276&quot;&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;
 &lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt;

&lt;!--[if gte mso 10]&gt;
&lt;style&gt;
 /* Style Definitions */
table.MsoNormalTable
 {mso-style-name:&quot;Table Normal&quot;;
 mso-tstyle-rowband-size:0;
 mso-tstyle-colband-size:0;
 mso-style-noshow:yes;
 mso-style-priority:99;
 mso-style-parent:&quot;&quot;;
 mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-para-margin:0in;
 mso-para-margin-bottom:.0001pt;
 mso-pagination:widow-orphan;
 font-size:10.0pt;
 font-family:&quot;Times New Roman&quot;;
 mso-fareast-language:JA;}
&lt;/style&gt;
&lt;![endif]--&gt;



&lt;!--StartFragment--&gt;





























































&lt;!--EndFragment--&gt;&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://dagmarliepamd.blogspot.com/feeds/6610571242507195382/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://dagmarliepamd.blogspot.com/2018/03/treatment-for-opioid-use-disorder.html#comment-form' title='2 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/3448774753580776110/posts/default/6610571242507195382'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/3448774753580776110/posts/default/6610571242507195382'/><link rel='alternate' type='text/html' href='https://dagmarliepamd.blogspot.com/2018/03/treatment-for-opioid-use-disorder.html' title='Treatment for Opioid Use Disorder Continues to Evolve - a brief summary'/><author><name>Anonymous</name><uri>http://www.blogger.com/profile/02352035717099209091</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>2</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3448774753580776110.post-1938822715902701594</id><published>2018-02-22T09:24:00.002-08:00</published><updated>2018-03-01T15:15:00.756-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="addiction"/><category scheme="http://www.blogger.com/atom/ns#" term="addiction treatment"/><category scheme="http://www.blogger.com/atom/ns#" term="alcoholism"/><category scheme="http://www.blogger.com/atom/ns#" term="Bunavail"/><category scheme="http://www.blogger.com/atom/ns#" term="buprenorphine"/><category scheme="http://www.blogger.com/atom/ns#" term="cravings"/><category scheme="http://www.blogger.com/atom/ns#" term="detox"/><category scheme="http://www.blogger.com/atom/ns#" term="outpatient"/><category scheme="http://www.blogger.com/atom/ns#" term="outpatient detox"/><category scheme="http://www.blogger.com/atom/ns#" term="sober"/><category scheme="http://www.blogger.com/atom/ns#" term="Sublocade. Subutex"/><category scheme="http://www.blogger.com/atom/ns#" term="substance abuse"/><category scheme="http://www.blogger.com/atom/ns#" term="Zubsolv"/><title type='text'>Detox - Not one size fits all</title><content type='html'>&lt;div class=&quot;p1&quot; style=&quot;box-sizing: border-box; color: #666666; font-family: &amp;quot;Open sans&amp;quot;; font-size: 15px; margin-bottom: 10px;&quot;&gt;
&lt;span class=&quot;s1&quot; style=&quot;box-sizing: border-box;&quot;&gt;There can be a lot of frustration when it comes to deciding how to get help with substance abuse and where and how to detox. There are many more choices than either spending $70K for a month in a beautiful place or simply going to a 12 step program.&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;p1&quot; style=&quot;box-sizing: border-box; color: #666666; font-family: &amp;quot;Open sans&amp;quot;; font-size: 15px; margin-bottom: 10px;&quot;&gt;
&lt;span class=&quot;s1&quot; style=&quot;box-sizing: border-box;&quot;&gt;Substance abuse can affect anyone in any profession or demographic. Almost everyone seeking sobriety feels overwhelmed by the cravings and withdrawal symptoms.&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;p1&quot; style=&quot;box-sizing: border-box; color: #666666; font-family: &amp;quot;Open sans&amp;quot;; font-size: 15px; margin-bottom: 10px;&quot;&gt;
&lt;span class=&quot;s1&quot; style=&quot;box-sizing: border-box;&quot;&gt;We believe that an integrated approach tailored to your specific needs addressing withdrawal symptoms as well as the underlying psychosocial issues can provide a path to recovery.&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;p1&quot; style=&quot;box-sizing: border-box; color: #666666; font-family: &amp;quot;Open sans&amp;quot;; font-size: 15px; margin-bottom: 10px;&quot;&gt;
&lt;span class=&quot;s1&quot; style=&quot;box-sizing: border-box;&quot;&gt;Innovative new medical treatments are now available that can greatly reduce, eliminate or manage the cravings and withdrawal symptoms. This medically monitored jump start into sobriety can give the you a new window of clarity through which you can start to address the underlying behavioral issues that are a major component of any addiction.&amp;nbsp;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;p1&quot; style=&quot;box-sizing: border-box; color: #666666; font-family: &amp;quot;Open sans&amp;quot;; font-size: 15px; margin-bottom: 10px;&quot;&gt;
&lt;span class=&quot;s1&quot; style=&quot;box-sizing: border-box;&quot;&gt;Whether it is group programs or private therapy, confronting the underlying issues that are part of addiction with a clearer mind provides the greatest chance of staying in recovery.&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;p1&quot; style=&quot;box-sizing: border-box; color: #666666; font-family: &amp;quot;Open sans&amp;quot;; font-size: 15px; margin-bottom: 10px;&quot;&gt;
&lt;span class=&quot;s1&quot; style=&quot;box-sizing: border-box;&quot;&gt;We recognize that substance abuse/addiction is a brain disease that is chronic and is always associated with underlying psycho-social issues that require personalized treatment.&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;p1&quot; style=&quot;box-sizing: border-box; color: #666666; font-family: &amp;quot;Open sans&amp;quot;; font-size: 15px; margin-bottom: 10px;&quot;&gt;
&lt;span class=&quot;s1&quot; style=&quot;box-sizing: border-box;&quot;&gt;Most of the treatments we offer are performed on an outpatient basis so you don’t have to miss time from work. We can assure you absolute confidentiality and comfort during this process. For more info contact us.&lt;/span&gt;&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://dagmarliepamd.blogspot.com/feeds/1938822715902701594/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://dagmarliepamd.blogspot.com/2018/02/detox-not-one-size-fits-all.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/3448774753580776110/posts/default/1938822715902701594'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/3448774753580776110/posts/default/1938822715902701594'/><link rel='alternate' type='text/html' href='https://dagmarliepamd.blogspot.com/2018/02/detox-not-one-size-fits-all.html' title='Detox - Not one size fits all'/><author><name>Anonymous</name><uri>http://www.blogger.com/profile/02352035717099209091</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry></feed>